News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2023-02-28 9:14:47 am Horizon Therapeutics: Attractive 5.4% Upside To Amgen Offer SeekingAlpha
2023-02-22 2:49:0 am Opiant Pharmaceuticals, Inc.'s (NASDAQ:OPNT) largest shareholders are individual investors with 52% ownership, institutions own 33% Simply Wall St.
2023-02-07 1:1:0 pm Opiant Pharmaceuticals Announces CFIUS Approval for Proposed Acquisition by Indivior PLC GlobeNewswire
2023-02-06 5:0:0 am Opiant Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition by Indivior PLC GlobeNewswire
2023-01-26 12:43:51 pm UPDATE 2-U.S. Senator Warren 'particularly concerned' about Amgen, Indivior deals Reuters
2023-01-26 9:35:18 am U.S. Senator Warren 'particularly concerned' about Amgen, Indivior deals Reuters
2023-01-26 9:7:38 am Warren tells FTC she is "particularly concerned" about Amgen and Indivior deals Reuters
2023-01-19 1:5:0 pm Opiant Pharmaceuticals Announces FDA Acceptance and Priority Review of NDA for OPNT003, Nasal Nalmefene, for Opioid Overdose GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information